Indications
Bleomycin Sulfate is indicated for palliation, and as a treatment adjuvant to surgery and radiation therapy, in the following neoplasms: squamous cell carcinoma of the skin, head and neck and oesophagus (primary indication), squamous cell carcinoma of the larynx, penis and uterine cervix, squamous cell carcinoma of the bronchus (response infrequent), choriocarcinoma and embryonal cell carcinoma of the testis, advanced Hodgkin's disease and other lymphomas, and mycosis fungoides.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Nobody knows exactly how bleomycin works. The main action is thought to be single and double-strand breaks in DNA, which stop cells from dividing and growing and also stop DNA synthesis in those cells. Bleomycin probably works best on cells in the M and G2 (premitotic) phase of the cell cycle.
In vitro, bleomycin has not been shown to suppress the immune system, and patients treated with it show no significant inhibition of immune response.
An enzyme that inactivates bleomycin has been found in both normal and malignant cells, and it is particularly prominent in the liver. It is not found in the lung or the skin, which are two normal tissues sensitive to the action of bleomycin.
Pregnancy & Breastfeeding
Bleomycin Sulfate is Pregnancy Category D. Nobody knows yet whether the medicine passes into human milk. Many drugs do pass into breast milk, and a nursing infant could have serious adverse reactions, so women who are receiving Bleomycin Sulfate therapy should stop nursing.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.